or Try an Advanced Search...

    Technical Analysis for TIL - Instil Bio, Inc.

    Grade Last Price % Change Price Change
    D 23.36 -10.84% -2.84
    TIL closed down 10.84 percent on Wednesday, November 20, 2024, on 28 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical TIL trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish -10.84%
    Wide Bands Range Expansion -10.84%
    Oversold Stochastic Weakness -10.84%
    NR7 Range Contraction -6.07%
    Stochastic Reached Oversold Weakness -6.07%
    Wide Bands Range Expansion -6.07%
    Older End-of-Day Signals for TIL ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Lower Bollinger Band about 17 hours ago
    Down 10% about 17 hours ago
    Outside Day about 18 hours ago
    Fell Below Previous Day's Low about 18 hours ago
    Down 5% about 18 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TIL Chart by TradingView
    Basic chart:

    Profile

    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Cell Therapy Non Small Cell Lung Cancer Melanoma Lymphocytes Cervical Cancer Head And Neck Squamous Cell Carcinoma Tumor Infiltrating Lymphocytes Cutaneous Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer

    Is TIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy
    Nov 13 Instil Bio files for $200M mixed securities shelf
    Nov 13 Instil Bio GAAP EPS of -$3.54
    Nov 13 Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Sep 25 2 Stocks Up Over 700% in 2024 That Could Soar Even Further
    Sep 17 Here's Why Everyone's Talking About Summit Therapeutics
    Sep 16 Crude Oil Surges Over 1%; Instil Bio Shares Plunge
    Sep 16 Instil Bio Stock Skyrockets 641% in One Week: Here's Why
    Sep 16 Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer
    Sep 15 Wall Street Breakfast: The Week Ahead
    See more TIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 92.0
    52 Week Low 6.07
    Average Volume 329,476
    200-Day Moving Average 19.61
    50-Day Moving Average 43.34
    20-Day Moving Average 29.68
    10-Day Moving Average 28.82
    Average True Range 4.03
    RSI (14) 35.48
    ADX 14.06
    +DI 22.03
    -DI 31.38
    Chandelier Exit (Long, 3 ATRs) 32.41
    Chandelier Exit (Short, 3 ATRs) 35.16
    Upper Bollinger Bands 36.65
    Lower Bollinger Band 22.71
    Percent B (%b) 0.05
    BandWidth 46.97
    MACD Line -3.40
    MACD Signal Line -3.21
    MACD Histogram -0.186
    Fundamentals Value
    Market Cap 151.93 Million
    Num Shares 6.5 Million
    EPS -30.20
    Price-to-Earnings (P/E) Ratio -0.77
    Price-to-Sales 55329.79
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 28.82
    Resistance 3 (R3) 29.33 28.02 27.91
    Resistance 2 (R2) 28.02 26.63 27.77 27.61
    Resistance 1 (R1) 25.69 25.77 25.04 25.18 27.30
    Pivot Point 24.38 24.38 24.05 24.13 24.38
    Support 1 (S1) 22.05 22.99 21.40 21.54 19.42
    Support 2 (S2) 20.74 22.13 20.49 19.11
    Support 3 (S3) 18.41 20.74 18.81
    Support 4 (S4) 17.90